Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies

Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the most frequently used medication to treat it. Several studies have investigated the benefits of methylphenidate, showing possible favourable effects on ADHD...

Full description

Bibliographic Details

Published in:	Cochrane database of systematic reviews Vol. 5; p. CD012069
Main Authors:	Storebø, Ole Jakob, Pedersen, Nadia, Ramstad, Erica, Kielsholm, Maja Lærke, Nielsen, Signe Sofie, Krogh, Helle B, Moreira-Maia, Carlos R, Magnusson, Frederik L, Holmskov, Mathilde, Gerner, Trine, Skoog, Maria, Rosendal, Susanne, Groth, Camilla, Gillies, Donna, Buch Rasmussen, Kirsten, Gauci, Dorothy, Zwi, Morris, Kirubakaran, Richard, Håkonsen, Sasja J, Aagaard, Lise, Simonsen, Erik, Gluud, Christian
Format:	Journal Article
Language:	English
Published:	England 10.05.2018
Subjects:	Adolescent Attention Deficit Disorder with Hyperactivity - drug therapy Central Nervous System Stimulants - adverse effects Central Nervous System Stimulants - therapeutic use Child Child, Preschool Humans Methylphenidate - adverse effects Methylphenidate - therapeutic use Non-Randomized Controlled Trials as Topic Patient Dropouts - statistics & numerical data Young Adult
ISSN:	1469-493X, 1469-493X
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!